American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 373-384 , March 2008

Prevalence and Factors Associated With CKD: A Population Study From Beijing

  • LuXia Zhang, MD

      Affiliations

    • Institute of Nephrology and Division of Nephrology, Peking University First Hospital, Beijing, China
    • L.Z. and P.Z. contributed equally to this work.
    • ,
  • PuHong Zhang, MD

      Affiliations

    • Institute of Chronic and Noncommunicable Disease Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, China
    • L.Z. and P.Z. contributed equally to this work.
    • ,
  • Fang Wang, MD

      Affiliations

    • Institute of Nephrology and Division of Nephrology, Peking University First Hospital, Beijing, China
    • ,
  • Li Zuo, MD

      Affiliations

    • Institute of Nephrology and Division of Nephrology, Peking University First Hospital, Beijing, China
    • ,
  • Ying Zhou, MD

      Affiliations

    • Institute of Chronic and Noncommunicable Disease Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, China
    • ,
  • Ying Shi, MD

      Affiliations

    • Institute of Chronic and Noncommunicable Disease Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, China
    • ,
  • Gang Li, MD

      Affiliations

    • Institute of Chronic and Noncommunicable Disease Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, China
    • ,
  • ShuFang Jiao, MD

      Affiliations

    • Institute of Chronic and Noncommunicable Disease Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, China
    • ,
  • ZeJun Liu, MD

      Affiliations

    • Institute of Chronic and Noncommunicable Disease Control and Prevention, Beijing Center for Disease Control and Prevention, Beijing, China
    • ,
  • WanNian Liang, MD

      Affiliations

    • Beijing Municipal Health Bureau, Beijing, China.
    • ,
  • HaiYan Wang, MD

      Affiliations

    • Institute of Nephrology and Division of Nephrology, Peking University First Hospital, Beijing, China
    • Corresponding Author InformationAddress correspondence to HaiYan Wang, MD, Institute of Nephrology and Division of Nephrology, Peking University First Hospital, No. 8 Xishiku St, Xicheng District, Beijing, 100034, PR China.

Received 22 July 2007 ,Accepted 29 November 2007.

References 

  1. Lysaght MJ. Maintenance dialysis population dynamics: Current trends and long-term implications. J Am Soc Nephrol. 2002;13(suppl 1):S37–S40
  2. Vanholder R, Massy Z, Argiles A, et al. Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant. 2005;20:1048–1056
  3. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10:1606–1615
  4. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(suppl 3):S112–S119
  5. Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
  6. Dirks JH, De Zeeuw D, Agarwal SK, et al. Prevention of chronic kidney and vascular disease: Toward global health equity—The Bellagio 2004 Declaration. Kidney Int Suppl. 2005;98:S1–S6
  7. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  8. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  9. Chadban SJ, Briganti EM, Kerr PG, et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003;14(suppl 2):S131–S138
  10. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284
  11. Chen J, Wildman RP, Gu D, et al. Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int. 2005;68:2837–2845
  12. Zhang L, Zuo L, Xu G, et al. Community-based screening for chronic kidney disease among populations older than 40 years in Beijing. Nephrol Dial Transplant. 2007;22:1093–1099
  13. Dialysis and Transplantation Registration Group CSoNCMA. The report about the registration of dialysis and transplantation in China 1999. Chin J Nephrol. 2001;17:77–78
  14. Fourth National Health and Nutrition Examination Survey Working Group. Results from the Fourth National Health and Nutrition Examination Survey of China. Acta Nutr Sin. 2004;26:417–420
  15. Liu LS, Chen MQ, Zeng GY, et al. A forty-year study on hypertension. Acta Acad Med Sin. 2002;24:401–408
  16. Wu YK, Lu CQ, Gao RQ. Nation-wide hypertension screening in China during 1979-1980. Chin Med J. 1982;95:101–108
  17. Hooi LS, Wong HS, Morad Z. Prevention of renal failure: The Malaysian experience. Kidney Int Suppl. 2005;94:S70–S74
  18. Tungsanga K, Ratanakul C, Pooltavee W, et al. Experience with prevention programs in Thailand. Kidney Int Suppl. 2005;94:S68–S69
  19. Mani MK. Experience with a program for prevention of chronic renal failure in India. Kidney Int Suppl. 2005;94:S75–S78
  20. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937–2944
  21. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: Programs and collection procedures. Vital Health Stat. 1994;32:11–407
  22. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  23. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2):S1–S266(suppl 1)
  24. Zuo L, Wang M. Current status of hemodialysis treatment in Beijing, China. Ethn Dis. 2006;16(suppl 2):S2–S4
  25. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  26. Hallan SI, Coresh J, Astor BC, et al. International comparison of the relationship of chronic kidney disease prevalence and ESRD risk. J Am Soc Nephrol. 2006;17:2275–2284
  27. United Nations, Economic and Social Development: World population prospects: the 2006 version. http://esa.un.org/unpp/p2k0data.aspAccessed September 5, 2007
  28. Brancati FL, Whelton PK, Randall BL, et al. Risk of end-stage renal disease in diabetes mellitus: A prospective cohort study of men screened for MRFIT (Multiple Risk Factor Intervention Trial). JAMA. 1997;278:2069–2074
  29. Tozawa M, Iseki K, Iseki C, et al. Blood pressure predicts risk of developing end-stage renal disease in men and women. Hypertension. 2003;41:1341–1345
  30. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13–18
  31. Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men (16-Year MRFIT findings). JAMA. 1997;277:1293–1298
  32. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79
  33. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69–75
  34. PRC National Blood Pressure Survey Cooperative Group. Hypertension prevalence and the status of people awareness, treatment and control in China: A national-wide survey in 1991. Chin J Hypertens. 1995;3(suppl 1):S14–S18
  35. Gu D, Reynolds K, Wu X, et al. Prevalence, awareness, treatment, and control of hypertension in China. Hypertension. 2002;40:920–927
  36. Xiang H, Wu W, Liu C. A epidemiological study on DM 1995-1996 in China. Chin J Diabetes. 1998;6:131–133
  37. Wirta OR, Pasternack AI, Mustonen JT, et al. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients. Nephrol Dial Transplant. 1996;11:449–456
  38. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: Association with slimming regimen including Chinese herbs. Lancet. 1993;341:387–391
  39. Li X, Wang H. Aristolochic acid nephropathy: What we know and what we have to do. Nephrology (Carlton). 2004;9:109–111
  40. Brunner FP, Selwood NH. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality (EDTA-ERA Registry Committee). Nephrol Dial Transplant. 1994;9:1371–1376
  41. Schwarz A, Preuschof L, Zellner D. Incidence of analgesic nephropathy in Berlin since 1983. Nephrol Dial Transplant. 1999;14:109–112
  42. De Smet PA. Herbal remedies. N Engl J Med. 2002;347:2046–2056
  43. Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal medicine: An overview of scientific evidence. Altern Ther Health Med. 1999;5:40–49
  44. Barsoum RS. End-stage renal disease in North Africa. Kidney Int Suppl. 2003;94:S111–S114
  45. Plata R, Silva C, Yahuita J, et al. The first clinical and epidemiological programme on renal disease in Bolivia: A model for prevention and early diagnosis of renal diseases in the developing countries. Nephrol Dial Transplant. 1998;13:3034–3036
  46. Li PK, Kwan BC, Leung CB, et al. Prevalence of silent kidney disease in Hong Kong: The screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program. Kidney Int Suppl. 2005;94:S36–S40
  47. Hall CL, Bradley R, Kerr A, et al. Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol. 2004;62:267–272
  48. Topham PS, Harper SJ, Furness PN, et al. Glomerular disease as a cause of isolated microscopic haematuria. Q J Med. 1994;87:329–335
  49. Liu G, Ma XZ, Zou WZ, et al. The prevalence of biopsy-proven renal diseases in adults between two periods over the past 10 years. J Clin Intern Med. 2004;21:834–838
  50. Szeto CC, Lai FM, To KF, et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med. 2001;110:434–437
  51. Centers for Disease Control and Prevention. Incidence of end-stage renal disease among persons with diabetes—United States 1990-2002. MMWR Morbid Mortal Wkly Rep. 2005;54:1097–1100

PII: S0272-6386(07)01562-4

doi: 10.1053/j.ajkd.2007.11.009

American Journal of Kidney Diseases
Volume 51, Issue 3 , Pages 373-384 , March 2008

Article Tools

* Image Usage & Resolution